0000000000860162

AUTHOR

Alfred Goldinger

showing 2 related works from this author

Topical treatment with a two-component gel releasing nitric oxide cures C57BL/6 mice from cutaneous leishmaniasis caused by Leishmania major.

2016

C57BL/6medicine.medical_specialty030231 tropical medicineDrug Evaluation PreclinicalLeishmaniasis CutaneousTopical treatmentDermatologyPharmacologyAdministration CutaneousBiochemistryNitric oxide030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCutaneous leishmaniasismedicineAnimalsLeishmania majorNitric Oxide DonorsMolecular BiologyLeishmania majorbiologybusiness.industryLeishmaniasisbiology.organism_classificationmedicine.diseaseDermatologyMice Inbred C57BLchemistrybusinessGelsExperimental dermatology
researchProduct

Pharmazeutische Betreuung von Patienten mit Osteoporose: „Fragen Sie Ihren Apotheker!”

2001

Pharmacologymedicine.medical_specialtyPharmaceutical carebusiness.industryFamily medicineOsteoporosismedicinePharmacistPharmaceutical SciencePharmacology (medical)businessmedicine.diseasePharmazie in unserer Zeit
researchProduct